SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences and afford the patient a better quality of life.

Neuropsychiatric systemic lupus erythematosus (NPSLE), or central nervous system ... In a new study, researchers reviewed ...

Neuropsychiatric manifestations of systemic lupus erythematosus (SLE ... and current treatments rely on clinical experience. This Review covers recent clinical advances in this area and emphasizes ...

Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

Clinical research has shown that patients with systemic lupus erythematosus (SLE) are more likely to develop cardiovascular ...

Panelists discuss the significant clinical and economic burdens ... How many patients have systemic lupus erythematosus (SLE)? How often do patients with SLE present with or develop LN?

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

Adult patients hospitalized for aseptic or septic revision TKA were eligible for inclusion. Patients with SLE were propensity score matched in a 1:4 ratio with individuals without the disease. The ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

In this difficult clinical situation ... rituximab? SLE: Systemic lupus erythematosus. Symptoms of systemic lupus erythematosus (SLE) must be brought under control to avert immediate consequences ...